Drs. Delgado and Kadkhodayan both presented at the 10th Annual Meeting of the Society of NeuroInterventional Surgery in Miami, FL this past July. CRL provides the highest level of neurointerventional care and is actively involved in numerous, high-impact clinic research studies. Above, Dr. Delgado presents “Last-Recorded P2Y12 Reaction Units Value Predicts Thromboembolic and Hemorrhagic Complications Occurring up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device”, among several other presentations. Dr. Kadkhodayan presented “Endovascular Treatment of Middle Cerebral Artery Aneurysms: a 16-Year Single-Center Experience”, which draws on the long history of quality neurointerventional care provided by CRL at Abbott Northwestern Hospital.